Sinovent
Small molecule drug development platform in China.
Launch date
Market cap
-
Enterprise valuation
$1.3b (Public information from Feb 2024)
Suzhou Shi Jiangsu (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Series A | ||
$145m | Series C | ||
* | CNY200m | Late VC | |
* | CNY700m Valuation: CNY9.5b | Series E | |
Total Funding | $269m |
Related Content
Recent News about Sinovent
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.